SERPING1 and hereditary angioedema: Molecular genetic testing is not considered as obligatory to confirm the diagnosis of C1-INH-HAE, though analyzing the segregation of novel SERPING1 variants in case of available family members is recommended to confirm the pathogenicity and penetrance (5).